SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-029221
Filing Date
2023-06-12
Accepted
2023-06-12 07:19:12
Documents
14
Period of Report
2023-06-09
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc20054252_8k.htm   iXBRL 8-K 38959
2 EXHIBIT 99.1 brhc20054252_ex99-1.htm EX-99.1 250025
3 EXHIBIT 99.2 brhc20054252_ex99-2.htm EX-99.2 12900
  Complete submission text file 0001140361-23-029221.txt   465088

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA avro-20230609.xsd EX-101.SCH 3862
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20230609_lab.xml EX-101.LAB 23290
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20230609_pre.xml EX-101.PRE 16550
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc20054252_8k_htm.xml XML 4383
Mailing Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139 617.914.8420
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 231007083
SIC: 2836 Biological Products, (No Diagnostic Substances)